Stock Scorecard



Stock Summary for Mimedx Group Inc (MDXG) - $9.06 as of 11/20/2024 8:25:44 PM EST

Total Score

15 out of 30

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MDXG

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MDXG

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MDXG

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MDXG

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MDXG (34 out of 90)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 8

Latest News for for MDXG

How Much Upside is Left in MiMedx ( MDXG ) ? Wall Street Analysts Think 37.12% 11/20/2024 2:55:00 PM
MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs 11/14/2024 2:15:00 PM
ChromaDex Corporation ( CDXC ) Hit a 52 Week High, Can the Run Continue? 11/5/2024 2:15:00 PM
Can MiMedx ( MDXG ) Climb 77.92% to Reach the Level Wall Street Analysts Expect? 11/4/2024 2:55:00 PM
MiMedx ( MDXG ) Q3 Earnings and Revenues Surpass Estimates 10/30/2024 9:25:00 PM
MIMEDX Announces Third Quarter 2024 Operating and Financial Results 10/30/2024 8:01:00 PM
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue - MiMedx Group ( NASDAQ:MDXG ) 10/8/2024 8:01:00 PM
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix - MiMedx Group ( NASDAQ:MDXG ) 7/31/2024 8:02:00 PM
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports 7/22/2024 12:10:00 PM
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives 7/17/2024 12:00:00 PM

Financial Details for MDXG

Company Overview

Ticker MDXG
Company Name Mimedx Group Inc
Country USA
Description MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 9.06
Price 4 Years Ago 9.08
Last Day Price Updated 11/20/2024 8:25:44 PM EST
Last Day Volume 963,708
Average Daily Volume 836,246
52-Week High 9.49
52-Week Low 5.47
Last Price to 52 Week Low 65.63%

Valuation Measures

Trailing PE 16.04
Industry PE 52.46
Sector PE 40.32
5-Year Average PE -35.57
Free Cash Flow Ratio 15.10
Industry Free Cash Flow Ratio 35.05
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 4.10
Total Cash Per Share 0.60
Book Value Per Share Most Recent Quarter 1.23
Price to Book Ratio 7.53
Industry Price to Book Ratio 5.44
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 3.98
Industry Price to Sales Ratio Twelve Trailing Months 13.48
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 146,946,000
Market Capitalization 1,331,330,760
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -9.70%
Annual Earnings Growth 292.83%
Reported EPS 12 Trailing Months 0.57
Reported EPS Past Year 0.24
Reported EPS Prior Year 0.32
Net Income Twelve Trailing Months 88,458,000
Net Income Past Year 58,228,000
Net Income Prior Year -30,197,000
Quarterly Revenue Growth YOY 2.90%
5-Year Revenue Growth -2.59%
Operating Margin Twelve Trailing Months 0.14

Balance Sheet

Total Cash Most Recent Quarter 88,801,000
Total Cash Past Year 82,000,000
Total Cash Prior Year 65,950,000
Net Cash Position Most Recent Quarter 70,783,000
Net Cash Position Past Year 32,000,000
Long Term Debt Past Year 50,000,000
Long Term Debt Prior Year 50,000,000
Total Debt Most Recent Quarter 18,018,000
Equity to Debt Ratio Past Year 0.74
Equity to Debt Ratio Most Recent Quarter 0.91
Total Stockholder Equity Past Year 142,717,000
Total Stockholder Equity Prior Year -17,988,000
Total Stockholder Equity Most Recent Quarter 181,008,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 50,460,000
Free Cash Flow Per Share Twelve Trailing Months 0.34
Free Cash Flow Past Year 24,788,000
Free Cash Flow Prior Year -19,407,000

Options

Put/Call Ratio 0.88
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.49
MACD Signal 0.34
20-Day Bollinger Lower Band 4.97
20-Day Bollinger Middle Band 6.64
20-Day Bollinger Upper Band 8.32
Beta 1.94
RSI 81.18
50-Day SMA 7.22
150-Day SMA 5.55
200-Day SMA 6.58

System

Modified 11/19/2024 6:30:05 AM EST